Payment of IRB fees is regarded as a contractual responsibility of the sponsor. The fees are assessments of actual cost associated with protocol review by the IRB and are charged for services rendered. Because the IRB commits its full resources to each review, the fees are due and payable in full by the sponsor upon receipt of the invoice, even if the IRB does not approve the study, subjects are never enrolled, or the study is terminated before objectives are reached. Approval will not be released until payment of IRB invoice is received.
IRB Review Category | Fees for studies submitted after 7/1/2009 |
---|---|
Full Board Review* | $2,400 |
Expedited Review* | $1,200 |
Exempt Status* | $500 |
Annual Reviews | $500 |
Revisions* | |
Major Changes (Full Board Review) | $500 |
Minor Changes (Expedited Review) | No charge |
Recruitment Materials | No charge |
Adverse Events | No charge |
*Appropriateness of review category determined by the IRB office. |
Kimberly C Mason, PharmD
Chair, IRB
865-305-9712
KMason@utmck.edu
Jen Engle, PhD, CIP
IRB Director
865-305-9781
jmengle@utmck.edu
Cindy Langley, RN, CIP
IRB Regulatory Specialist
865-305-6892
clangley@utmck.edu
The Institutional Review Board (IRB)
UTHSC Graduate School of Medicine
3rd Floor, U76
1924 Alcoa Highway
Knoxville, TN 37920
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2023